Tatva Chintan Pharma - Quaterly Results

05 May 2023 Evaluate
A fair growth of 17.20% in the revenue at Rs. 1194.06 millions was reported in the March 2023 quarter as compared to Rs. 1018.80 millions during year-ago period.The Company's Net profit for the March 2023 quarter have declined marginally to Rs. 161.54  millions as against Rs. 188.87 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 161.86 millions from 232.91 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1194.06 1018.80 17.20 4030.44 4278.11 -5.79 4030.44 4278.11 -5.79
Other Income 7.83 11.92 -34.31 56.78 106.29 -46.58 56.78 106.29 -46.58
PBIDT 161.86 232.91 -30.51 603.56 1163.97 -48.15 603.56 1163.97 -48.15
Interest 31.79 11.81 169.18 83.84 49.51 69.34 83.84 49.51 69.34
PBDT 94.20 221.10 -57.39 483.85 1114.46 -56.58 483.85 1114.46 -56.58
Depreciation 25.30 21.47 17.84 95.54 81.80 16.80 95.54 81.80 16.80
PBT 68.90 199.63 -65.49 388.31 1032.66 -62.40 388.31 1032.66 -62.40
TAX -92.64 10.76 -960.97 -16.34 72.79 -122.45 -16.34 72.79 -122.45
Deferred Tax -48.04 -24.23 98.27 -35.93 -107.29 -66.51 -35.93 -107.29 -66.51
PAT 161.54 188.87 -14.47 404.65 959.87 -57.84 404.65 959.87 -57.84
Equity 221.65 221.65 0.00 221.65 221.65 0.00 221.65 221.65 0.00
PBIDTM(%) 13.56 22.86 -40.71 14.98 27.21 -44.96 14.98 27.21 -44.96

Tatva Chintan Pharma Share Price

1387.00 -31.50 (-2.22%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×